Overview
The actively managed fund is focused on capturing growth and income opportunities predominantly from Europe.
It invests predominantly in European equities, high yield corporate bonds and convertible bonds.
Each asset class weighting is kept at approximately one third.
The portfolio manager is not tied to the benchmark in terms of investment selection or weight.
This share class distributes a constant percentage share of the NAV, not a constant amount.
This share class is designed for investors who want to profit from performance opportunities on the financial markets and at the same time wish more stable distributions at a specific percentage level to cover recurring liquidity needs.
As the distributions are substantial, this share class is not designed for investors who want to build wealth. The latter may prefer the accumulating share class.
This share class must not be seen as an alternative to a savings account or fixed-interest paying investments.
The percentage distribution rate of this share class is unrelated to the interest or other income generated in the fund. The distribution is a percentage payment of the current amount of investment.
It is possible that the distributions result in an erosion of assets and a reduction of invested capital.
This share class may distribute capital as well as income. There are potential negative tax consequences for some investors in some jurisdictions. See risk section below.
Benefits
Equities, high yield corporate bonds and convertible bonds offer a compelling combination of growth and income opportunities with favorable risk/return characteristics.
Diversification across each asset class at approximately one third reduces overall risk.
Managed by a dedicated team of experts who can draw upon UBS SA国际传谋's experienced European investment teams.
Risks
Features
| Product category |
UBS Asset Allocation Funds UBS European Growth and Income Fund |
| Product domicile |
Luxembourg
|
| Portfolio management |
UBS SA国际传谋 (UK) Ltd., London
|
| Fund management |
UBS SA国际传谋 (Europe) S.A., Luxembourg
|
| Custodian bank |
UBS Europe SE, Luxembourg Branch
|
| Representative for products established under foreign law |
UBS Fund Management (Switzerland) AG
|
| Day of inception |
August 11, 2014
|
| Currency of account |
AUD
|
| Close of financial year |
September 30
|
| SFDR Classification |
Art.6
|
| Issue / redemption |
daily
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
1.82% p.a.
|
| Management fee |
1.40% p.a.
|
| Total expense ratio (TER) |
1.82% p.a.
|
| Swing pricing |
yes
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
Customized Benchmark
|
| Securities no. |
24921231
|
| ISIN |
LU1089952383
|
| Bloomberg Ticker |
UEGIPAU LX
|
| Telekurs Id |
n.a.
|
Performance and Prices
Percentage growth
as of April 23, 2026| AUD(%) | |
| YTD | 4.40 |
| 1M | |
| 3M | |
| 6M | |
| 1Y | |
| 2Y | 13.41 |
| 3Y | |
| 5Y | 26.99 |
| ø p.a.5Y | 4.90 |
Current data
| Net asset value | 23.04.2026 | AUD 76.94 |
| High - last 12 months | 26.02.2026 | AUD 78.77 |
| Low - last 12 months | 24.04.2025 | AUD 72.10 |
| Last distribution | 15.04.2026 | AUD 0.50 |
| Assets of the unit class in mn | 23.04.2026 | AUD 26.72 |
| Total product assets in mn | 23.04.2026 | AUD 652.38 |
| Indicative equity dividend yield (gross) | 31.03.2026 | 3.15% |
Structures
By the 10 largest equity positions (in %, as of March 31, 2026)
|
|
|
| ASML HOLDING NV | 0.76 |
| DEUTSCHE TELEKOM AG | 0.66 |
| NOVARTIS AG | 0.65 |
| ASTRAZENECA PLC | 0.63 |
| SHELL PLC | 0.61 |
By the 10 largest positions (in %, as of March 31, 2026)
|
|
|
| UBS Lux Bond Fund - Convert Europe EUR | 19.25 |
| UBS Lux Key Selection Sicav - European Equity Value Opportunity | 14.60 |
| UBS Lux Bond SICAV - Convert Global EUR | 14.49 |
| UBS Lux Equity SICAV - European Opportunity Unconstrained EUR | 14.12 |
| UBS Lux Equity SICAV - European High Dividend EUR | 5.21 |
| Nidda Healthcare Holding GmbH | 1.10 |
| Teva Pharmaceutical Finance Netherlands II BV | 1.02 |
| Aroundtown Finance Sarl | 0.78 |
| ZF Europe Finance BV | 0.73 |
| Pinnacle Bidco PLC | 0.60 |
Fees
Distributions
|
Date of distribution
|
Pay date
|
Cps no.
|
Currency
|
Distribution
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12.05.2025 | 15.05.2025 | 128 | AUD | 0.49 | 10.06.2025 | 13.06.2025 | 129 | AUD | 0.49 | 10.07.2025 | 15.07.2025 | 130 | AUD | 0.49 | 11.08.2025 | 14.08.2025 | 131 | AUD | 0.49 | 10.09.2025 | 15.09.2025 | 132 | AUD | 0.50 | 10.10.2025 | 15.10.2025 | 133 | AUD | 0.50 | 10.11.2025 | 13.11.2025 | 134 | AUD | 0.50 | 10.12.2025 | 15.12.2025 | 135 | AUD | 0.50 | 12.01.2026 | 15.01.2026 | 136 | AUD | 0.50 | 10.02.2026 | 13.02.2026 | 137 | AUD | 0.51 | 10.03.2026 | 13.03.2026 | 138 | AUD | 0.52 | 10.04.2026 | 15.04.2026 | 139 | AUD | 0.50 |
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
| Statutes / Management regulations |
|
|
|
Document type
|
Document Language
|
||
| Annual report |
|
|
|
| Semi-annual report |
|
|
|
|
Document type
|
Document Language
|
|||
| Tax list |
|
|
|
|